Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.

AusPAR: Pegaspargase

Australian Public Assessment Report

AusPAR

AusPAR: Pegaspargase [PDF, 1.45 MB]

AusPAR: Pegaspargase [DOCX, 2.13 MB]

Attachment: Product Information: Pegaspargase [PDF, 218.43 KB]

Attachment: Product Information: Pegaspargase [DOCX, 130.43 KB]

Attachment: Extract from Clinical Evaluation Report: Pegaspargase [PDF, 9.47 MB]

Attachment: Extract from Clinical Evaluation Report: Pegaspargase [DOCX, 17.3 MB]

Device/Product Name

Oncaspar

Active ingredients

Pegaspargase

AusPAR Date

18 September 2018

Published

8 November 2018

Submission Number

PM-2016-02333-1-4

Submission Type

New biological entity

Decision

Approved

Product types

Prescription medicines